Catalyst Wire Dossier Catalyst Wire Dossier

1064 nm nonablative skin rejuvenation treatment

· Cutera Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 1064 nm nonablative skin rejuvenation treatment, covering 2023-09-06 to 2023-09-06. Get the full timeline:

Most recent: Clinical Trial Update: A Single-Center Open-Label Study of 1064 nm for Nonablative Skin Rejuvenation [NA]

See pricing